UCR biomedical scientist joins international SARS-CoV-2 group assembled by NIAID
SAVE focuses on mutations in SARS-CoV-2 and emerging virus variants
Should you get a second booster shot for COVID-19?
UC Riverside’s Dr. David Lo, a vaccine expert, shares his thoughts
A potential antiviral for SARS and SARS-like coronaviruses
UC Riverside-led study shows how an effective therapy against SARS-CoV-2 could be developed
Scientists profile FDA-approved drugs to potentially treat hundreds of genetic disorders
New method developed by UC Riverside researchers quickly assesses drug potential for rare disorders
Researchers develop molecular traps to target SARS-CoV-2
Joint effort by UC Riverside and UCLA scientists aims to stop the COVID-19-spreading virus from attacking immune cells
Scientists discover new avian immunological pathway
UC Riverside-led team identifies a new host protein interaction that produces a robust immune response to viral infection in birds and may lead to better poultry vaccines
Is it time to wear a highly efficient medical grade facemask?
UC Riverside experts weigh in
A more targeted therapy to treat inflammatory bowel disease
UC Riverside mouse study focuses on the receptor TNFR1
New hope for people living with a genetic cause of autism
UC Riverside research shows gene reactivation can be used to treat Fragile X syndrome
O my, here’s Omicron
UC Riverside experts share their thoughts on the new COVID-19 variant
Study links high cholesterol, cardiovascular disease to plastics
UC Riverside-led mouse study finds a receptor greatly contributes to the harmful effects of plastic-associated chemicals
Deafness trumps HIV for deaf people living with HIV
UC Riverside-led study participants advocate for collection of more data on deaf individuals
New model links cultural trauma with health inequalities
UC Riverside researchers offer new interpretation of cultural trauma